Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Donors were not age- or sex-matched across experiments, and the number of donors was selected based on conventions in the primary T cell delivery literature rather than a formal power calculation.24,86,90,93,102”
From Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles (2026) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, S., Cheng, Q., Wei, T., Yu, X., Johnson, L. T., Farbiak, L., & Siegwart, D. J. (2021) · Nature Materials · doi:10.1038/s41563-020-00886-0 · Cited by 653
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Patel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith, J. P., Hou, S., Esposito, A. A., Ketova, T., Welsher, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14527-2 · Cited by 601
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
Swingle, K. L., Safford, H. C., Geisler, H. C., Hamilton, A. G., Thatte, A. S., Billingsley, M. M., Joseph, R. A., Mrksich, K., Padilla, M. S., Ghalsasi, A. A., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c12893 · Cited by 145
mRNA lipid nanoparticle formulation, characterization and evaluation
Ma, Y., VanKeulen-Miller, R., & Fenton, O. S. (2025) · Nature Protocols · doi:10.1038/s41596-024-01134-4 · Cited by 54
Self-citationEfficient mRNA delivery to resting T cells to reverse HIV latency
Cevaal, P. M., Kan, S., Fisher, B. M., Moso, M. A., Tan, A., Liu, H., Ali, A., Tanaka, K., Shepherd, R. A., Kim, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60001-2 · Cited by 38
Research works printed but not linked: 62
- 10.1021/acs.molpharmaceut.2c00010 · DOI
- 10.1021/ar3000162 · DOI · Paper page
- 10.1038/s41573-020-0090-8 · DOI · Paper page
- 10.1038/s41578-021-00358-0 · DOI · Paper page
- 10.1021/acs.molpharmaceut.4c00871 · DOI
- 10.1038/s41586-020-1951-3 · DOI · Paper page
- 10.1038/s41392-023-01471-y · DOI · Paper page
- 10.1016/j.addr.2021.113996 · DOI
- 10.1126/sciadv.abe7853 · DOI
- 10.1038/s41577-019-0203-y · DOI · Paper page
- 10.1021/acsami.4c22969 · DOI
- 10.1016/j.bbrc.2014.05.043 · doi:10.1016/j.bbrc.2014.05.043
- 10.1021/acs.molpharmaceut.7b01055 · DOI · Paper page
- 10.1016/j.jconrel.2022.06.052 · DOI
- 10.1016/j.ejpb.2024.114468 · DOI
- 10.1016/j.biomaterials.2021.121339 · DOI · Paper page
- 10.1038/s41571-023-00811-9 · DOI · Paper page
- 10.1002/smll.202304378 · DOI · Paper page
- 10.1016/j.ymthe.2021.06.004 · DOI · Paper page
- 10.1021/jacs.4c04565 · DOI
- 10.3390/pharmaceutics13122097 · DOI
- 10.1038/s42003-021-02441-2 · DOI · Paper page
- 10.1101/2023.02.15.528720 · DOI
- 10.1039/D1BM01454D · DOI · Paper page
- 10.1126/science.8134835 · DOI · Paper page
- 10.1039/D0BM01609H · DOI · Paper page
- 10.1039/D0BM01947J · DOI · Paper page
- 10.1002/adtp.202200305 · DOI
- 10.1021/acs.nanolett.0c01386 · DOI · Paper page
- 10.1021/acs.bioconjchem.4c00419 · DOI
- 10.1021/acs.nanolett.5b02497 · DOI · Paper page
- 10.1002/smll.202303568 · DOI
- 10.3390/biomedicines11102752 · DOI
- 10.1016/j.ijpharm.2023.122874 · DOI
- 10.1002/adhm.202500245 · DOI
- 10.1038/s44222-025-00339-w · DOI
- 10.1021/jacs.3c05574 · DOI
- 10.1002/btm2.10161 · DOI · Paper page
- 10.1016/j.jconrel.2022.05.020 · DOI
- 10.1111/all.15187 · DOI
- 10.1021/nn403325f · DOI · Paper page
- 10.1016/j.addr.2023.115042 · DOI
- 10.1016/j.jconrel.2020.08.031 · DOI
- 10.1021/acs.molpharmaceut.3c00803 · DOI
- 10.1021/acs.bioconjchem.3c00205 · DOI
- 10.1021/acsabm.3c00721 · DOI
- 10.1016/j.coi.2010.01.018 · DOI · Paper page
- 10.1016/j.jve.2023.100342 · DOI
- 10.1021/jacs.3c02584 · DOI
- 10.1016/j.canlet.2009.01.002 · DOI · Paper page
- 10.1371/journal.ppat.1004473 · DOI · Paper page
- 10.1128/mbio.01632-24 · DOI · Paper page
- 10.1101/312447 · DOI
- 10.1074/jbc.M402124200 · DOI · Paper page
- 10.1158/2326-6066.CIR-22-0494 · DOI
- 10.1101/2021.08.20.457104 · DOI
- 10.1016/j.xpro.2025.104025 · DOI
- 10.1038/d41586-023-01745-z · DOI
- 10.1261/rna.701307 · DOI · Paper page
- 10.1039/D2BM01804G · DOI
- 10.1039/D4BM00038B · DOI
- 10.1016/j.addr.2007.08.034 · DOI · Paper page
Cited by
Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.103081
Metadata
- Authors
- VanKeulen-Miller, R., Huff, J., Narasipura, E. A., Browne, E. P., & Fenton, O. S.
- Affiliations
- Department of Pharmacology, School of Medicine
- Department of Microbiology and Immunology
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2025-11-25
- Volume
- 19
- Issue
- 49
- Pages
- 41836-41849
- ISSN
- 1936-0851
- 1936-086X
- Cited by
- 17
- References
- 7
- Language
- en
- Licence
- Funders
- National Institutes of Health (1R35GM157060, R01DA064083, R56-AI-143381, UM1-AI-164567)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells. https://app.cochat.ai/papers/10.1021/acsnano.5c15903
- The paper
- VanKeulen-Miller, R., Huff, J., Narasipura, E. A., Browne, E. P., & Fenton, O. S. (2025). Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells. ACS Nano. https://doi.org/10.1021/acsnano.5c15903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.